News & Updates
Showing Neurology articles
Showing

Donanemab BLAZEs through Alzheimer’s treatment TRAIL in first active comparator trial
The first study to directly compare two disease-modifying agents for Alzheimer’s disease (AD), the phase III TRAILBLAZER-ALZ 4 study shows promising efficacy and safety data on donanemab vs aducanumab for the treatment of early symptomatic AD.

Gut dysbiosis evident in patients with prodromal PD and their first-degree relatives
A cross-sectional study from the Chinese University of Hong Kong suggests that Parkinson’s disease (PD)–like gut dysbiosis occurs at preclinical prodromal stages of PD, in patients with video-polysomnography (v-PSG)–confirmed REM sleep behavior disorder (RBD) and even in their younger first-degree relatives (RBD-FDR).

Cash transfers ease functional impairment in elderly
A study in India has shown the effectiveness of a small cash transfer in alleviating short-term functional impairment among older people who are living alone. However, cash transfers do not produce a clinically or statistically significant decrease in depression and show no impact on food security.





